Illumina (ILMN)
(Delayed Data from NSDQ)
$100.11 USD
+0.14 (0.14%)
Updated Oct 24, 2025 04:00 PM ET
After-Market: $100.11 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Illumina, Inc. has a market cap of $15.37B, which represents its share price of $99.97 multiplied by its outstanding shares number of 153.70M. As a large-cap company, ILMN's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ILMN 100.11 +0.14(0.14%)
Will ILMN be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for ILMN based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for ILMN
Illumina (ILMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Keros Therapeutics (KROS) Moves 9.8% Higher: Will This Strength Last?
ILMN: What are Zacks experts saying now?
Zacks Private Portfolio Services
PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations
KMDA or ILMN: Which Is the Better Value Stock Right Now?
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Other News for ILMN
Earnings week ahead: AAPL, MSFT, AMZN, META, GOOG, BA, XOM, CVX, PFE, MA, V, PYPL, SOFI, and more
Is ILMN poised for gains? MACD Bullish Centerline Cross shows up after gaining 0.14%
ILMN Crossed Above 50 Day Moving Average on October 23
Illumina price target lowered to $105 from $106 at Baird
Illumina price target lowered by $1 at Baird, here's why